Glaucoma treatment. A review of people with primary open-angle glaucoma and ocular hypertension concluded that medical IOP lowering treatment slowed down the progression of visual field loss. Vascular flow and neurodegenerative theories of glaucomatous optic neuropathy have prompted studies on various neuroprotective therapeutic strategies, including nutritional compounds, some of which may be regarded by clinicians as safe for use now, while others are on trial. Intraocular pressure can be lowered with medication, usually eye drops. Several classes of medications are used to treat glaucoma, with several medications in each class. Each of these medicines may have local and systemic side effects.
Phacolytic glaucoma likely to suffer from phacolytic glaucoma it is an effective procedure which can take place during the cataract surgery used to correct phacolytic glaucoma and improve the quality of life of sufferers. The youngest patient found to be diagnosed with Phacolytic Glaucoma was 35 years of age , which thereby highlights its significant prevalence in senior patients. Moreover, Phacolytic Glaucoma is more likely seen in underdeveloped countries as a result of the lack of access to ophthalmologic care. When being faced with Phacolytic Glaucoma most cases ameliorate when the cataract is extracted thereby enhancing vision. On the other hand, this